pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-216b |
Genomic Coordinates | chr2: 56000714 - 56000795 |
Description | Homo sapiens miR-216b stem-loop |
Comment | This sequence was identified as a miRNA candidate by Berezikov et al. using RAKE and MPSS techniques . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-216b-3p | ||||||||||||||||||||||||||||||||||||
Sequence | 49| ACACACUUACCCGUAGAGAUUCUA |72 | ||||||||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SMC5 | ||||||||||||||||||||
Synonyms | SMC5L1 | ||||||||||||||||||||
Description | structural maintenance of chromosomes 5 | ||||||||||||||||||||
Transcript | NM_015110 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SMC5 | |||||||||||||||||||||
3'UTR of SMC5 (miRNA target sites are highlighted) |
>SMC5|NM_015110|3'UTR 1 TAAAAGTAAAGAGAGGGAACTTGGGAATTTTTTTTGTTAAATTCTGTTTATAAGTATGGCTCAACTGAATAAAAGGAGAT 81 TCACTAAAACGAAAAGCAGTTATTTTTGGAAACCTGCTTTTAAATACAAATAGGTTGATAATGGAAACTATAATGACCTT 161 TCCAAAATAGCAGCTGGTAGTAAAAGTTAAGTCTTCTTCAGTCTTGGTTGAACTTGAGTTCTTGGCACTCTGACCATGAG 241 TCATTCAGTTCTCATGTTAAAATGTACTTAATATTACAAATCAAAGGTACAGTGGAAGAAGGGTTAATCACAAGAAGTTA 321 CTTATATGGTAGCCCTGAGCTTTAATTGCAGAGTAACTTTAATTACTTTTAGAGCCTAAAGATGACTCTAGAGCCTAAGT 401 CCTAGTTTCTCCCAATGTTATATTTAATTTTAAAAAATTGATATGAAAATGTCTAATGTATAGTAATAATTTATGACAGA 481 TCTAGTCATTTCTTCCTATTAAAAAAGATTACCTTATCTCCAGTAGGAAATGGAATTTTATGGGCCTTTAAAAGAAAGTT 561 TTATGAAACTTGATGCTATAATTTTATTGGTATTTCAAGGGGAAAAAAGCACTGGGGTTCAAAAATGGTAGCAGAACTGC 641 TTTGAAATGCTGCAAGGTGGCCACTAGATGATGCAAAATACAACCAAAAGATTGACTGAGAATAAAATTAGGTGACAAGG 721 GTTTTTAAAGAATAACCTTTTAAAGTGTGGGGGCAGGGGTTGCTTTTTTTTATTTTATTTAAAGTCAATTATATTTTACA 801 TCTTACATTTCTAAAAGCATTTTATAATTATTTTTAGTAAGATTTTTCTTAAAATTTCATATACTGGTTTCTACAATTTA 881 TATTTGAAATTTCTCAGTGTTATGTAAAGAGTGATGGAAAAGCATTGATTTCTTTAAAACCGTAATGTTTTTAGAACTTA 961 AGCCTATAGGGCCTTTCTTACAATGTTGATGTACCCATTATCTTAGAAAATCTAGTTTAAACTGTTTTCTTTCACCGCAA 1041 AAGAATTAAATGGGAAAATCATTTGTTTATCTCTAAGTTATACTAATTAGTAGAACCAAACAAATTATCTTCTTTTAAAA 1121 AATAAATCTTATAGGAAAATAGACAGTCCAAAGTCATGTCTTTGAACAGTGGATTGGATCTGTGCCAGTAATGACAAAAT 1201 TATTTTTTTGACTTGCTTGCCTGAATAAATTGAAGAATTGCTTTCAGTTTGGGTTTTGTATATTCTTAAGTAGCCATTGA 1281 AATTTATATTCTTAACTAGGTCAAAAAATAATGAGCCATAAGTTTATGTCCTCTCACTTAGACATTTTCTCTTTAAAAAG 1361 GTATTTTCTTCTTTATAAACATTTTAAAAGAGCCTTCCCTTCTTAAACTAACTCCAGTGCATGAAGTGTGAAAATATTTT 1441 AAAATGACATTTTTACTAATATGAGCAAGTCATGTAAACATTGAAGAACTTGGTAACATATTAGTAAATGGATATTACCA 1521 AATGTTTTCATCGTTAATTACTTTGCGTTCCACCAAAATATCTTTACTAAAATGTGCTTGGTGTAGTTTGTTTATTGTCT 1601 AAATTAGTACCAGTCATCTTATTTCTGCAAAATGAGTATCAATGTGAAAAAGACACGTGAAGATTAAGCATGTTTGAAAA 1681 TAAAATGGTCAATTACATTTCAATTTACATAGGCCAACAACTGTTCCATACTTTGTTTGTAAACATTTAATTTCTCTACT 1761 GGACAAAATTAATATTTGGCTTTACATTGAATTTTGAGCTGTGAAGAATAAATTATGTATCATTTTAGCATATTAAACAG 1841 TAGTAAGTCTAGCACATAGTCTCAGCCACTTAAAACAAAAGTTTTTTTGTTTGTTTGTTTGTTTGTTTTTTTGAGATGGA 1921 GTCTCACTCTGTTGCCCAGGCTGGAGTGCAGTGGCGTGATCTCGGCTTACTGCAACCTCCGCCTCCCGGGTTCAAGCGAT 2001 TCTCCTGCCTCAGCCTCCCAAGTAACTGGGACAACAGGCGCGTCCCACCACACCCAGCTAATTTTTTATACTTTTAGTAG 2081 AGATGGGGTTTCAGCATATTGGCCAGGCTGGTCTCGAACTCCTGACCTTGTGATCCACCCGCCTCGGCCTCCCAAAGTGC 2161 TGGGATTATAGGCGTGAGCCCCTGCACCCGGCCAAAAGTTGATTTTTAATTACATAAAAATCGTAAAAACTTCTAGTAAA 2241 AACTTGATTTGGTGAATACAGTTATATTTAAAAACCTTAAGGTGACAAGCATTTTCTATGCCTAAATCTTCATTGGTTTG 2321 CCTGGAAAGAGTCTCTGTTAAAAGATTTTCCATATTCAAAGTAAAAGGAAAGATTTCTTGCTTTCTAATTGTCTTTTGGA 2401 CACATGCCTATTTTCTTTGAGGTATAAACCTTTAGATGTGAAAAATGTAATTTCATTCTGCTATTGTGTGTGCTTGTGTG 2481 TGTGTAATTGAAAAAACTGGGAAATCCTGCTTTGTTGGTAATAAATCAATATTTTTATATTC Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462573. RNA binding protein: AGO2. Condition:TZM-bl BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462573 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl BaL |
Location of target site | ENST00000361138.5 | 3UTR | AACUCCAGUGCAUGAAGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
111 hsa-miR-216b-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT071722 | CCNK | cyclin K | 2 | 2 | ||||||||
MIRT074768 | CNEP1R1 | CTD nuclear envelope phosphatase 1 regulatory subunit 1 | 2 | 2 | ||||||||
MIRT101407 | SSR1 | signal sequence receptor subunit 1 | 2 | 2 | ||||||||
MIRT241289 | AASDHPPT | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 2 | 4 | ||||||||
MIRT268292 | CCND1 | cyclin D1 | 2 | 8 | ||||||||
MIRT445347 | IFNA6 | interferon alpha 6 | 2 | 2 | ||||||||
MIRT446663 | MXI1 | MAX interactor 1, dimerization protein | 2 | 4 | ||||||||
MIRT447595 | MSH3 | mutS homolog 3 | 2 | 2 | ||||||||
MIRT448485 | SEMA4F | ssemaphorin 4F | 2 | 2 | ||||||||
MIRT450309 | DRAXIN | dorsal inhibitory axon guidance protein | 2 | 2 | ||||||||
MIRT451850 | TXNDC5 | thioredoxin domain containing 5 | 2 | 2 | ||||||||
MIRT483613 | SMC5 | structural maintenance of chromosomes 5 | 2 | 2 | ||||||||
MIRT485633 | EEPD1 | endonuclease/exonuclease/phosphatase family domain containing 1 | 2 | 2 | ||||||||
MIRT499766 | CIRH1A | UTP4, small subunit processome component | 2 | 6 | ||||||||
MIRT503337 | MMAB | methylmalonic aciduria (cobalamin deficiency) cblB type | 2 | 2 | ||||||||
MIRT513007 | MAN1A2 | mannosidase alpha class 1A member 2 | 2 | 2 | ||||||||
MIRT513529 | RHOQ | ras homolog family member Q | 2 | 4 | ||||||||
MIRT521499 | RAB11B | RAB11B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT524335 | CRK | CRK proto-oncogene, adaptor protein | 2 | 4 | ||||||||
MIRT524731 | BRI3BP | BRI3 binding protein | 2 | 8 | ||||||||
MIRT525326 | SNX29 | sorting nexin 29 | 2 | 2 | ||||||||
MIRT526264 | CCDC169 | coiled-coil domain containing 169 | 2 | 2 | ||||||||
MIRT527428 | NRL | neural retina leucine zipper | 2 | 2 | ||||||||
MIRT527512 | ZNF134 | zinc finger protein 134 | 2 | 2 | ||||||||
MIRT528881 | ATF3 | activating transcription factor 3 | 2 | 2 | ||||||||
MIRT529578 | IGBP1 | immunoglobulin binding protein 1 | 2 | 4 | ||||||||
MIRT531122 | ZYG11B | zyg-11 family member B, cell cycle regulator | 2 | 2 | ||||||||
MIRT531341 | TGIF2LX | TGFB induced factor homeobox 2 like, X-linked | 2 | 2 | ||||||||
MIRT532433 | DHX33 | DEAH-box helicase 33 | 2 | 2 | ||||||||
MIRT534032 | STX7 | syntaxin 7 | 2 | 2 | ||||||||
MIRT534538 | SACS | sacsin molecular chaperone | 2 | 4 | ||||||||
MIRT538886 | BRWD3 | bromodomain and WD repeat domain containing 3 | 2 | 2 | ||||||||
MIRT539628 | CD19 | CD19 molecule | 2 | 8 | ||||||||
MIRT540327 | ATAT1 | alpha tubulin acetyltransferase 1 | 2 | 8 | ||||||||
MIRT540353 | OCLN | occludin | 2 | 6 | ||||||||
MIRT540699 | ATG10 | autophagy related 10 | 2 | 4 | ||||||||
MIRT541033 | STRBP | spermatid perinuclear RNA binding protein | 2 | 8 | ||||||||
MIRT541945 | NBPF10 | NBPF member 10 | 2 | 4 | ||||||||
MIRT543505 | PLS1 | plastin 1 | 2 | 2 | ||||||||
MIRT551164 | UBTF | upstream binding transcription factor, RNA polymerase I | 2 | 4 | ||||||||
MIRT551790 | ZNF117 | zinc finger protein 117 | 2 | 4 | ||||||||
MIRT553227 | TWF1 | twinfilin actin binding protein 1 | 2 | 2 | ||||||||
MIRT559622 | AKIRIN2 | akirin 2 | 2 | 2 | ||||||||
MIRT559719 | ADORA2B | adenosine A2b receptor | 2 | 2 | ||||||||
MIRT564600 | ZNF781 | zinc finger protein 781 | 2 | 2 | ||||||||
MIRT567015 | KLHL15 | kelch like family member 15 | 2 | 2 | ||||||||
MIRT569564 | C7orf26 | chromosome 7 open reading frame 26 | 2 | 2 | ||||||||
MIRT572155 | DDX3X | DEAD-box helicase 3, X-linked | 2 | 2 | ||||||||
MIRT575399 | Zdhhc22 | zinc finger, DHHC-type containing 22 | 2 | 5 | ||||||||
MIRT607322 | PKNOX1 | PBX/knotted 1 homeobox 1 | 2 | 4 | ||||||||
MIRT607953 | NFAM1 | NFAT activating protein with ITAM motif 1 | 2 | 10 | ||||||||
MIRT607979 | ZDHHC22 | zinc finger DHHC-type containing 22 | 2 | 7 | ||||||||
MIRT609145 | ZNF610 | zinc finger protein 610 | 2 | 4 | ||||||||
MIRT609206 | GOSR2 | golgi SNAP receptor complex member 2 | 2 | 4 | ||||||||
MIRT609338 | HRASLS5 | HRAS like suppressor family member 5 | 2 | 2 | ||||||||
MIRT609725 | KIF5C | kinesin family member 5C | 2 | 4 | ||||||||
MIRT610014 | MED24 | mediator complex subunit 24 | 2 | 4 | ||||||||
MIRT610407 | TMEM245 | transmembrane protein 245 | 2 | 2 | ||||||||
MIRT610559 | NBPF14 | NBPF member 14 | 2 | 2 | ||||||||
MIRT611291 | PAGR1 | PAXIP1 associated glutamate rich protein 1 | 2 | 2 | ||||||||
MIRT611399 | ATP9A | ATPase phospholipid transporting 9A (putative) | 2 | 2 | ||||||||
MIRT611432 | C11orf45 | chromosome 11 open reading frame 45 | 2 | 4 | ||||||||
MIRT611710 | SLFN13 | schlafen family member 13 | 2 | 2 | ||||||||
MIRT611721 | ANK3 | ankyrin 3 | 2 | 2 | ||||||||
MIRT611830 | CACNG8 | calcium voltage-gated channel auxiliary subunit gamma 8 | 2 | 4 | ||||||||
MIRT611977 | ZNF175 | zinc finger protein 175 | 2 | 2 | ||||||||
MIRT612073 | CEP135 | centrosomal protein 135 | 2 | 4 | ||||||||
MIRT612195 | CCDC77 | coiled-coil domain containing 77 | 2 | 2 | ||||||||
MIRT612320 | UBE2H | ubiquitin conjugating enzyme E2 H | 2 | 2 | ||||||||
MIRT612354 | TNRC6C | trinucleotide repeat containing 6C | 2 | 4 | ||||||||
MIRT612635 | PTEN | phosphatase and tensin homolog | 2 | 2 | ||||||||
MIRT612773 | MLXIP | MLX interacting protein | 2 | 4 | ||||||||
MIRT612788 | MAP3K9 | mitogen-activated protein kinase kinase kinase 9 | 2 | 4 | ||||||||
MIRT612853 | JAZF1 | JAZF zinc finger 1 | 2 | 2 | ||||||||
MIRT612965 | GID4 | GID complex subunit 4 homolog | 2 | 6 | ||||||||
MIRT613132 | DUSP6 | dual specificity phosphatase 6 | 2 | 2 | ||||||||
MIRT613388 | AAK1 | AP2 associated kinase 1 | 2 | 2 | ||||||||
MIRT615058 | CRY2 | cryptochrome circadian clock 2 | 2 | 4 | ||||||||
MIRT616046 | HSPA12B | heat shock protein family A (Hsp70) member 12B | 2 | 2 | ||||||||
MIRT617962 | SEPT9 | septin 9 | 2 | 2 | ||||||||
MIRT618413 | ATP2A2 | ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 | 2 | 2 | ||||||||
MIRT622448 | RNF213 | ring finger protein 213 | 2 | 2 | ||||||||
MIRT623611 | IPCEF1 | interaction protein for cytohesin exchange factors 1 | 2 | 2 | ||||||||
MIRT625709 | SHROOM1 | shroom family member 1 | 2 | 2 | ||||||||
MIRT630646 | ELK1 | ELK1, ETS transcription factor | 2 | 2 | ||||||||
MIRT630970 | KIAA2022 | neurite extension and migration factor | 2 | 2 | ||||||||
MIRT631003 | SPAG7 | sperm associated antigen 7 | 2 | 2 | ||||||||
MIRT640385 | EMC1 | ER membrane protein complex subunit 1 | 2 | 4 | ||||||||
MIRT641064 | WBSCR17 | polypeptide N-acetylgalactosaminyltransferase 17 | 2 | 2 | ||||||||
MIRT641780 | ZDHHC7 | zinc finger DHHC-type containing 7 | 2 | 4 | ||||||||
MIRT646310 | MPHOSPH8 | M-phase phosphoprotein 8 | 2 | 2 | ||||||||
MIRT646624 | CENPL | centromere protein L | 2 | 2 | ||||||||
MIRT659653 | CDH2 | cadherin 2 | 2 | 2 | ||||||||
MIRT666161 | SP1 | Sp1 transcription factor | 2 | 2 | ||||||||
MIRT667638 | LHFPL2 | LHFPL tetraspan subfamily member 2 | 2 | 2 | ||||||||
MIRT668988 | CHRFAM7A | CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion | 2 | 2 | ||||||||
MIRT680949 | PLCXD1 | phosphatidylinositol specific phospholipase C X domain containing 1 | 2 | 2 | ||||||||
MIRT695238 | PBK | PDZ binding kinase | 2 | 2 | ||||||||
MIRT700036 | RPL22 | ribosomal protein L22 | 2 | 2 | ||||||||
MIRT707685 | GPR50 | G protein-coupled receptor 50 | 2 | 2 | ||||||||
MIRT709324 | HMBOX1 | homeobox containing 1 | 2 | 2 | ||||||||
MIRT710176 | MTRF1L | mitochondrial translational release factor 1 like | 2 | 2 | ||||||||
MIRT712007 | F9 | coagulation factor IX | 2 | 2 | ||||||||
MIRT714219 | C10orf71 | chromosome 10 open reading frame 71 | 2 | 2 | ||||||||
MIRT714496 | HSPA4 | heat shock protein family A (Hsp70) member 4 | 2 | 2 | ||||||||
MIRT714575 | GALNT10 | polypeptide N-acetylgalactosaminyltransferase 10 | 2 | 2 | ||||||||
MIRT715982 | TFRC | transferrin receptor | 2 | 2 | ||||||||
MIRT717870 | TRAPPC3L | trafficking protein particle complex 3 like | 2 | 2 | ||||||||
MIRT718289 | MINA | ribosomal oxygenase 2 | 2 | 2 | ||||||||
MIRT725200 | PTRF | caveolae associated protein 1 | 2 | 2 | ||||||||
MIRT737338 | TPX2 | TPX2, microtubule nucleation factor | 3 | 0 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|